Fibrogen Inc CS
409 ILLINOIS STREETSAN FRANCISCO CA 94158 USA
P: 415-978-1200
F: 415-978-1902
http://www.fibrogen.com
Sectors & Indices
Sector
Industry
Employees
Profile
FibroGen, Inc. is a research-based biotechnology company. It is focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. The Company develops Roxadustat that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; and FG-3019 which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis. FibroGen, Inc. is headquartered in San Francisco, California.
Key Executives
Name | Title |
---|---|
Information not available. |